clinmedКлиническая медицинаClinical Medicine (Russian Journal)0023-21492412-1339ООО «Медицинское информационное агентство»10.30629/0023-2149-2022-100-7-8-368-376clinmed-426Research ArticleОБЗОРЫ И ЛЕКЦИИREVIEWS AND LECTURESСпециальные опросники, оценивающие качество жизни у пациентов с глаукомойSpecial questionnaires assessing the quality of life in patients with glaucomahttps://orcid.org/0000-0003-3436-0293ПароваЕ. Б.ParovaE. B.

Парова Елизавета Башировна — аспиранткафедры офтальмологии лечебного факультета 

117997, Москва

Parova Elizaveta B.

117997, Moscow

https://orcid.org/0000-0001-9606-0566КуроедовА. В.KuroedovA. V.

Куроедов Александр Владимирович — д-р мед. наук, начальник отделения офтальмологии, профессор кафедры офтальмологии лечебного факультета 

117997, Москва; 107014, Москва

Kuroedov Aleksandr V.

117997, Moscow; 107014, Moscow

ФГАОУ ВО «Российский национальный исследовательский медицинский университет им. Н.И. Пирогова» Минздрава РоссииРоссияPirogov Russian National Research Medical University (Pirogov Medical University)Russian FederationФГАОУ ВО «Российский национальный исследовательский медицинский университет им. Н.И. Пирогова» Минздрава России; ФКУ «Центральный военный клинический госпиталь им. П.В. Мандрыка» Минобороны РоссииРоссияPirogov Russian National Research Medical University (Pirogov Medical University); Central Military Clinical Hospital named after P.V. Mandrykа of the Ministry of Defense of RussiaRussian Federation2022311020221007-8368376Copyright © Парова Е.Б., Куроедов А.В., 20222022Парова Е.Б., Куроедов А.В.Parova E.B., Kuroedov A.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.clinmedjournal.com/jour/article/view/426

На основании анализа литературы установлена значимость оценки качества жизни (КЖ) больных глаукомой среди пациентов с иными офтальмологическими заболеваниями. Из-за высокого риска полной потери зрения важно добиться остановки прогрессирования глаукомы. Для этого развивающиеся нарушения зрительных функций отслеживают по уровню КЖ и ограничений работоспособности. В литературе подчеркивается важность адекватного контроля за течением заболевания и предлагаются различные методы оценки КЖ. Тем не менее задача поиска более чувствительных методов, позволяющих обнаружить наиболее ранние клинические проявления заболевания, остается нерешенной. Данная проблема важна для контроля приверженности к лечению, так как прогрессирующее ухудшение зрения вследствие глаукомы влияет на КЖ, поэтому такой мониторинг находит широкое применение при хронических заболеваниях, к которым относится и глаукома. Понимание влияния болезни на жизнедеятельность больных позволяет выбрать правильную стратегию лечения, улучшить сотрудничество с пациентом и его комплаенс, то есть соблюдение им рекомендаций врача.

The signifi cance of assessing the quality of life (QoL) in patients with glaucoma among those with other ophthalmic diseases has been established based on the analysis of literature. Due to the high risk of complete loss of vision, it is important to stop the progression of glaucoma. To do this, developing disorders of visual functions are monitored by the level of QoL and disability. The literature emphasizes the importance of adequate control over the course of the disease and off ers various methods for assessing QoL. Nevertheless, the goal of fi nding more sensitive methods of the earliest clinical manifestations detection, remains unresolved. This problem is important for monitoring adherence to treatment, since the progressive vision deterioration due to glaucoma, aff ects QoL, so such monitoring is widely used in chronic diseases, which include glaucoma. Understanding the impact of the disease on the life of patients allows one to choose the right treatment strategy, improve cooperation with the patient and his compliance, that is, compliance with the doctor’s recommendations.

качество жизни пациентовпервичная открытоугольная глаукомаопросникианкетыquality of lifeprimary open-angle glaucomaquestionnairesapplication formReferencesПарова Е.Б., Куроедов А.В. Преимущества и недостатки современных опросников для пациентов с глаукомой. Современные технологии в офтальмологии. 2020;3(34):34–35.Parova E.B., Kuroedov A.V. Advantages and disadvantages of modern questionnaires for patients with glaucoma. Modern Technologies in Ophthalmology. 2020;3(34):34–35. (In Russian).Апрелев А.Е., Барбос Ю.А., Муханько И.Ж. Эффективность нейро протекторной терапии у пациентов с глаукомой. Саратовский научно-медицинский журнал. 2018;14(4):828–831.Aprelev A.E., Barbos Yu.A., Mukhanko I.J. The eff ectiveness of neuroprotective therapy in patients with glaucoma. Saratov J. Scientifi c Medical. 2018;14(4):828–831. (In Russian).Овечкин И.Г., Малышев А.В., Карапетов Г.Ю. и др. Методы оценки качества жизни пациента в офтальмологической практике. Современная оптометрия. 2015;7(87):34–39.Ovechkin I.G., Malyshev A.V., Karapetov G.Yu. et al. Methods of assessing the patient’s quality of life in ophthalmological practice. Modern Optometry. 2015;7(87):34–39. (In Russian).Корелина В.Е., Газизова И.Р. Возрастные аспекты привер женности терапии глаукомы. Эффективная фармакотерапия. 2021; 17(37):34–39.Korelina V.E., Gazizova I.R. Age-related aspects of adherence to glaucoma therapy. Eff ective Pharmacotherapy. 2021; 17(37):34–39. (In Russian) DOI 10.33978/2307-3586-2021-17-37-34-39Радыш И.В., Рагозин О.Н., Шаламова Е.Ю. Выявление ла тентных факторов качества жизни, связанного со здоровьем, как методологический подход к его оценке и коррекции: Учеб. пособие. Москва, Российский университет дружбы народов (РУДН), 2017.Radysh I.V. Identifi cation of latent factors of health-related quality of life as a methodological approach to its assessment and correction: Textbook. I.V. Radysh, O.N. Ragozin, E. Y. Shalamova. Moscow, Peoples’ Friendship University of Russia (RUDN), 2017 (In Russian).Cahill M.T., Banks A.D., Stinnett S.S. et al. Vision-related quality of life in patients with bilateral severe age-related macular degeneration. Ophthalmology. 2005;112(1):152–158. DOI: 10.1016/j.ophtha.2004.06.036Cahill M.T., Banks A.D., Stinnett S.S. et al. Vision-related quality of life in patients with bilateral severe age-related macular degeneration. Ophthalmology. 2005;112(1):152–158. DOI: 10.1016/j.ophtha.2004.06.036Jacobs J.M., Hammerman-Rozenberg R., Maaravi Y. et al. The impact of visual impairment on health, function and mortality. Aging Clin. Exp. Res. 2005;17:281–286. DOI: 10.1007/BF03324611Jacobs J.M., Hammerman-Rozenberg R., Maaravi Y. et al. The impact of visual impairment on health, function and mortality. Aging Clin. Exp. Res. 2005;17:281–286. DOI: 10.1007/BF03324611Nutheti R., Shamanna B.R., Nirmalan P.K. et al. Impact of impaired vision and eye disease on quality of life in Andhra Pradesh. Invest. Ophthalmol. Vis. Sci. 2006;47:4742–4748. DOI: 10.1167/iovs.06-0020Nutheti R., Shamanna B.R., Nirmalan P.K. et al. Impact of impaired vision and eye disease on quality of life in Andhra Pradesh. Invest. Ophthalmol. Vis. Sci. 2006;47:4742–4748. DOI: 10.1167/iovs.06-0020Testa M.A., Simonson D.C. Assesment of quality-of-life outcomes. N. Engl. J. Med. 1996;334:835–840. DOI: 10.1056/NEJM199603283341306Testa M.A., Simonson D.C. Assesment of quality-of-life outcomes. N. Engl. J. Med. 1996;334:835–840. DOI: 10.1056/NEJM199603283341306Макогон С.И., Макогон А.С. Влияние различных моделей терапевтического обучения пациентов с первичной открыто угольной глаукомой на качество жизни. Клиническая геронтология. 2018;24(7–8):12–19.Makogon S.I., Makogon A.S. The infl uence of various models of therapeutic training of patients with primary open-angle glaucoma on the quality of life. Clinical Gerontology. 2018;24(7–8):12–19. (In Russian) DOI: 10.26347/1607-2499201807-08012-019Новик А.А., Ионова Т.И., Кайнд П. Концепция исследования качества жизни в медицине. СПб.: Элби, 1999.Novik A.A., Ionova T.I., Kaind P. The concept of quality of life research in medicine. St. Petersburg: Albi, 1999. (In Russian).Aaronson N.K. Quality of life assessment in clinical trials: methodologic issues. Control Clin. Trials. 1989;10(4):195–208. DOI: 10.1016/0197-2456(89)90058-5.Aaronson N.K. Quality of life assessment in clinical trials: methodologic issues. Control Clin. Trials. 1989;10(4):195–208. DOI: 10.1016/0197-2456(89)90058-5.Bullinger M., Power M.J., Aaronson N.K. et al. Creating and evaluating cross-cultural instruments. In: Spilker B., editor. Quality of life and pharmacoeconomics in clinical trials. Philadelphia: Lippincott-Raven Publishers. 1996:659–669.Bullinger M., Power M.J., Aaronson N.K. et al. Creating and evaluating cross-cultural instruments. In: Spilker B., editor. Quality of life and pharmacoeconomics in clinical trials. Philadelphia: Lippincott-Raven Publishers. 1996:659–669.Calvert M., Blazeby J., Altman D.G. et al. CONSORT PRO Group. Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension. JAMA. 2013;309(8):814–822. DOI: 10.1001/jama.2013.879Calvert M., Blazeby J., Altman D.G. et al. CONSORT PRO Group. Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension. JAMA. 2013;309(8):814–822. DOI: 10.1001/jama.2013.879Pollard W.E., Bobbitt R.A., Bergner M. et al. The sickness impact profi le: reliability of a health status measure. Med. Care. 1976; 14(2):146–155. DOI: 10.1097/00005650-197602000-00004Pollard W.E., Bobbitt R.A., Bergner M. et al. The sickness impact profi le: reliability of a health status measure. Med. Care. 1976; 14(2):146–155. DOI: 10.1097/00005650-197602000-00004Snyder C.F., Aaronson N.K., Choucair A.K. et al. Implementing patient-reported outcomes assessment in clinical practice: a review of the options and considerations. Qual. Life Res. 2012;21(8):1305– 1314. DOI: 10.1007/s11136-011-0054-xSnyder C.F., Aaronson N.K., Choucair A.K. et al. Implementing patient-reported outcomes assessment in clinical practice: a review of the options and considerations. Qual. Life Res. 2012;21(8):1305– 1314. DOI: 10.1007/s11136-011-0054-xСыркин А.Л., Печорина Е.А., Дриницина С.И. Валидизация методик оценки качества жизни у больных стабильной стенокардией. Клиническая медицина. 2001;79(1)1:22–25.Syrkin A.L., Pechorina E.A., Drinitsina S.I. Validation of methods for assessing the quality of life in patients with stable angina pectoris. Clinical Medicine. 2001;79(1)1:22–25. (In Russian).Курышева Н.И., Шарова Г.А., Беликова Е.И. Исследование роли хориоидеи и хрусталика в развитии первичного закрытия угла передней камеры: оценка качества жизни пациентов. Глаукома. 2022;21(1):3–13.Kurysheva N.I., Sharova G.A., Belikova E.I. Investigation of the role of the choroid and lens in the development of primary closure of the anterior chamber angle: assessment of the quality of life of patients. Glaucoma. 2022;21(1):3–13. (In Russian). DOI: 10.53432/2078-4104-2022-21-1-3-13Сахнов С.Н. Качество жизни больных глаукомой как интегральный критерий эффективности лечения. Здравоохранение Российской Федерации. 2018;62(5):234–238.Sakhnov S.N. Quality of life of glaucoma patients as an integral criterion of treatment effectiveness. Healthcare of the Russian Federation. 2018;62(5):234– 238. (In Russian). DOI: 10.18821/0044-197Х-2018-62-5-234-238Guillemin F. Cross-cultural adaptation and validation of health status measures. Scand. J. Rheumatol. 1995;24:61–63. DOI: 10.3109/03009749509099285Guillemin F. Cross-cultural adaptation and validation of health status measures. Scand. J. Rheumatol. 1995;24:61–63. DOI: 10.3109/03009749509099285Lee B.L., Gutierrez P., Gordon M. et al. The Glaucoma Symptom Scale. A brief index of glaucoma-specifi c symptoms. Arch. Ophthalmol. 1998;116:861–866. DOI: 10.1001/archopht.116.7.861Lee B.L., Gutierrez P., Gordon M. et al. The Glaucoma Symptom Scale. A brief index of glaucoma-specifi c symptoms. Arch. Ophthalmol. 1998;116:861–866. DOI: 10.1001/archopht.116.7.861Spaeth G., Walt J., Keener J. Evaluation of quality of life for patients with glaucoma. Am. J. Ophthalmol. 2006;141:3–14. DOI: 10.1016/j.ajo.2005.07.075Spaeth G., Walt J., Keener J. Evaluation of quality of life for patients with glaucoma. Am. J. Ophthalmol. 2006;141:3–14. DOI: 10.1016/j.ajo.2005.07.075Broman A.T., Munoz B., West S.K. et al. Psychometric properties of the 25-item NEI-VFQ in a Hispanic population: Proyecto VER. Invest. Ophthalmol. Vis. Sci. 2001;42:606-613.Broman A.T., Munoz B., West S.K. et al. Psychometric properties of the 25-item NEI-VFQ in a Hispanic population: Proyecto VER. Invest. Ophthalmol. Vis. Sci. 2001;42:606-613.Lin J.C., Chie W.C. Psychometric validation of the Taiwan Chinese version of the 25-Item National Eye Institute Visual Functioning Questionnaire. J. Eval. Clin. Pract. 2010;16:619–626. DOI: 10.1111/j.1365-2753.2009.01253.xLin J.C., Chie W.C. Psychometric validation of the Taiwan Chinese version of the 25-Item National Eye Institute Visual Functioning Questionnaire. J. Eval. Clin. Pract. 2010;16:619–626. DOI: 10.1111/j.1365-2753.2009.01253.xNordmann J.P., Viala M., Sullivan K. et al. Psychometric Validation of the National Eye Institute Visual Function Questionnaire-25 (NEI VFQ-25) French version: in a population of patients treated for ocular hypertension and glaucoma. Pharmacoeconomics. 2004;22:197–206. DOI: 10.2165/00019053-200422030-00005Nordmann J.P., Viala M., Sullivan K. et al. Psychometric Validation of the National Eye Institute Visual Function Questionnaire-25 (NEI VFQ-25) French version: in a population of patients treated for ocular hypertension and glaucoma. Pharmacoeconomics. 2004;22:197–206. DOI: 10.2165/00019053-200422030-00005Rossi G.C., Milano G., Tinelli C. The Italian version of the 25-item National Eye Institute Visual Function Questionnaire: translation, validity, and reliability. J. Glaucoma. 2003;12:213–220. DOI: 10.1097/00061198-200306000-00006Rossi G.C., Milano G., Tinelli C. The Italian version of the 25-item National Eye Institute Visual Function Questionnaire: translation, validity, and reliability. J. Glaucoma. 2003;12:213–220. DOI: 10.1097/00061198-200306000-00006Simao L.M., Lana-Peixoto M.A., Araujo C.R. et al. The Brazilian version of the 25-Item National Eye Institute Visual Function Questionnaire: translation, reliability and validity. Arq. Bras. Oftalmol. 2008;71(4):540–546. DOI: 10.1590/S0004-27492008000400014Simao L.M., Lana-Peixoto M.A., Araujo C.R. et al. The Brazilian version of the 25-Item National Eye Institute Visual Function Questionnaire: translation, reliability and validity. Arq. Bras. Oftalmol. 2008;71(4):540–546. DOI: 10.1590/S0004-27492008000400014Toprak A.B., Eser E., Guler C. et al. Cross-validation of the Turkish version of the 25-item National Eye Institute Visual Functioning Questionnaire (NEI-VFQ 25). Ophthalmic Epidemiol. 2005;12:259– 269. DOI: 10.1080/09286580590967763Toprak A.B., Eser E., Guler C. et al. Cross-validation of the Turkish version of the 25-item National Eye Institute Visual Functioning Questionnaire (NEI-VFQ 25). Ophthalmic Epidemiol. 2005;12:259– 269. DOI: 10.1080/09286580590967763Габдрахманова А.Ф., Курбанов С.А. Клинико-функциональное зна чение показателей качества жизни при первичной от крыто угольной глаукоме. Национальный журнал Глаукома. 2015; 14(4):29–35.Gabdrakhmanova A.F., Kurbanov S.A. Clinical and functional signifi cance of quality of life indicators in primary open-angle glaucoma. National J. Glaucoma. 2015;14(4):29–35. (In Russian)Khadka J., Pesudovs K., McAlinden C. et al. Reengineering the glaucoma quality of life-15 questionnaire with rasch analysis. Invest. Ophthalmol. Vis. Sci. 2011;52(9):6971–6977. DOI: 10.1167/iovs.11-7423Khadka J., Pesudovs K., McAlinden C. et al. Reengineering the glaucoma quality of life-15 questionnaire with rasch analysis. Invest. Ophthalmol. Vis. Sci. 2011;52(9):6971–6977. DOI: 10.1167/iovs.11-7423Skalicky S.E., Fenwick E., Martin K.R. et al. Impact of age-related macular degeneration in patients with glaucoma: understanding the patients’ perspective. Clin. Exp. Ophthalmol. 2016;44(5):377–387. DOI: 10.1111/ceo.12672Skalicky S.E., Fenwick E., Martin K.R. et al. Impact of age-related macular degeneration in patients with glaucoma: understanding the patients’ perspective. Clin. Exp. Ophthalmol. 2016;44(5):377–387. DOI: 10.1111/ceo.12672Goh R.L.Z., Fenwick E., Skalicky S.E. The Visual Function Questionnaire. J. Glaucoma. 2016; 25(10): 822-829. DOI: 10.1097/IJG.0000000000000441Goh R.L.Z., Fenwick E., Skalicky S.E. The Visual Function Questionnaire. J. Glaucoma. 2016; 25(10): 822-829. DOI: 10.1097/IJG.0000000000000441Mahdaviazad H., Roustaei, N., Masoumpour, M.B. et al. Psychometric properties of the Glaucoma Quality of Life-15 questionnaire: Use of explanatory factor analysis. J. Cur. Ophthalmol. 2018;30(3):211– 216. DOI: 10.1016/j.joco.2017.12.005Mahdaviazad H., Roustaei, N., Masoumpour, M.B. et al. Psychometric properties of the Glaucoma Quality of Life-15 questionnaire: Use of explanatory factor analysis. J. Cur. Ophthalmol. 2018;30(3):211– 216. DOI: 10.1016/j.joco.2017.12.005Barber B.L., Strahlman E.R., Laibovitz R. et al. Validation of a Questionnaire for Comparing the Tolerability of Ophthalmic Medications. Ophthalmology. 2020;104(2):334–342. DOI: 10.1016/s0161-6420(97)30314-5Barber B.L., Strahlman E.R., Laibovitz R. et al. Validation of a Questionnaire for Comparing the Tolerability of Ophthalmic Medications. Ophthalmology. 2020;104(2):334–342. DOI: 10.1016/s0161-6420(97)30314-5Musch D., Lichter P., Guire K. et al. The collaborative initial glaucoma treatment study Study design, methods, and baseline characteristics of enrolled patients. Ophthalmology. 1999;106(4),653–662. DOI: 10.1016/s0161-6420(99)90147-1Musch D., Lichter P., Guire K. et al. The collaborative initial glaucoma treatment study Study design, methods, and baseline characteristics of enrolled patients. Ophthalmology. 1999;106(4),653–662. DOI: 10.1016/s0161-6420(99)90147-1Nelson P., Aspinall P., Papasouliotis O. Quality of life in glaucoma and its relationship with visual function. J. Glaucoma. 2003;12(2):139–150. DOI: 10.1097/00061198-200304000-00009Nelson P., Aspinall P., Papasouliotis O. Quality of life in glaucoma and its relationship with visual function. J. Glaucoma. 2003;12(2):139–150. DOI: 10.1097/00061198-200304000-00009Viswanathan A.C., Mcnaught A., Poinoosawmy D. et al. Severity and Stability of Glaucoma: Patient Perception Compared With Objective Measurement. Arch. Ophthalmol. 1999;117:450–454. DOI: 10.1001/archopht.117.4.450Viswanathan A.C., Mcnaught A., Poinoosawmy D. et al. Severity and Stability of Glaucoma: Patient Perception Compared With Objective Measurement. Arch. Ophthalmol. 1999;117:450–454. DOI: 10.1001/archopht.117.4.450Iester M., Zingirian M. Quality of life in patients with early, moderate and advanced glaucoma. Eye. 2002;16(1):44–49. DOI: 10.1038/sj.eye.6700036Iester M., Zingirian M. Quality of life in patients with early, moderate and advanced glaucoma. Eye. 2002;16(1):44–49. DOI: 10.1038/sj.eye.6700036Walt J.G., Rendas-Baum R., Kosinski M. et al. Psychometric Evaluation of the Glaucoma Symptom Identifi er. J. Glaucoma. 2011;20(3):148–159. DOI: 10.1097/IJG.0b013e3181e07970Walt J.G., Rendas-Baum R., Kosinski M. et al. Psychometric Evaluation of the Glaucoma Symptom Identifi er. J. Glaucoma. 2011;20(3):148–159. DOI: 10.1097/IJG.0b013e3181e07970Tan K.L., Fhun L.C., Yaakub M. et al. Anxiety and Visual Field Assessment Reliability in Glaucoma Patients. Asian J. Med. Health. 2017;7(3):1–8. DOI: 10.9734/AJMAH/2017/36396Tan K.L., Fhun L.C., Yaakub M. et al. Anxiety and Visual Field Assessment Reliability in Glaucoma Patients. Asian J. Med. Health. 2017;7(3):1–8. DOI: 10.9734/AJMAH/2017/36396Atkinson M. J., Stewart W.C., Fain J.M. et al. Health Qual Life Outcomes. 2003;1:1–67. DOI: 10.1186/1477-7525-1-67Atkinson M. J., Stewart W.C., Fain J.M. et al. Health Qual Life Outcomes. 2003;1:1–67. DOI: 10.1186/1477-7525-1-67Béchetoille A., Arnould B., Bron A. et al. Measurement of health-related quality of life with glaucoma: validation of the Glau-QoL 36-item questionnaire. Acta Ophthalmologica. 2008;86(1):71–80. DOI: 10.1111/j.1600-0420.2007.00999.xBéchetoille A., Arnould B., Bron A. et al. Measurement of health-related quality of life with glaucoma: validation of the Glau-QoL 36-item questionnaire. Acta Ophthalmologica. 2008;86(1):71–80. DOI: 10.1111/j.1600-0420.2007.00999.xMusch D.C., Tarver M.E., Goren M.J., Janz N.K. Development of an 18-Item Measure of Symptom Burden in Patients With Glaucoma From the Collaborative Initial Glaucoma Treatment Study’s Symptom and Health Problem Checklist. JAMA Ophthalmol. 2017;135(12):1345–1351. DOI: 10.1001/jamaophthalmol.2017.4574Musch D.C., Tarver M.E., Goren M.J., Janz N.K. Development of an 18-Item Measure of Symptom Burden in Patients With Glaucoma From the Collaborative Initial Glaucoma Treatment Study’s Symptom and Health Problem Checklist. JAMA Ophthalmol. 2017;135(12):1345–1351. DOI: 10.1001/jamaophthalmol.2017.4574Sleath B., Blalock S.J., Robin A. Development of an instrument to measure glaucoma medication self-effi cacy and outcome expectations. Eye. 2009;24(4):624–631. DOI: 10.1038/eye.2009.174Sleath B., Blalock S.J., Robin A. Development of an instrument to measure glaucoma medication self-effi cacy and outcome expectations. Eye. 2009;24(4):624–631. DOI: 10.1038/eye.2009.174Regnault A., Viala-Danten M., Gilet H., Berdeaux G. Scoring and psychometric properties of the Eye-Drop Satisfaction Questionnaire (EDSQ), an instrument to assess satisfaction and compliance with glaucoma treatment. BMC Ophthalmol. 2010;10(1):1–9. DOI: 10.1186/1471-2415-10-1Regnault A., Viala-Danten M., Gilet H., Berdeaux G. Scoring and psychometric properties of the Eye-Drop Satisfaction Questionnaire (EDSQ), an instrument to assess satisfaction and compliance with glaucoma treatment. BMC Ophthalmol. 2010;10(1):1–9. DOI: 10.1186/1471-2415-10-1/

The authors declare that there are no conflicts of interest present.